Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abbott Launches NeuroSphere Virtual Clinic For Remote Neurostim Programming

Executive Summary

The US FDA approved Abbott's system that allows physicians to communicate with patients and remotely program their neuromodulation device.

You may also be interested in...



Abbott’s Next-Generation Spinal Cord Stimulator Gets FDA Nod

The newly approved Proclaim Plus system allows physicians to treat as many as six independent pain sites and choose the lowest-possible effective dose for each site.

Abbott’s Plan For DBS Depression Therapy Wins FDA’s Breakthrough Designation

Abbott continued St. Jude Medical’s prior research on deep brain stimulation for treating depression and has advanced the technology far enough that the US FDA now believes it could be a breakthrough treatment for treatment-resistant depression.

Abbott Seeks Expanded Labeling For CardioMEMS HF Monitor Based On GUIDE HF Results

The GUIDE HF investigators contend the trial missed its primary endpoint because of COVID-19.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT143615

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel